Secondary uses and the governance of de-identified data: Lessons from the human genome diversity panel
<p>Abstract</p> <p>Background</p> <p>Recent changes to regulatory guidance in the US and Europe have complicated oversight of secondary research by rendering most uses of de-identified data exempt from human subjects oversight. To identify the implications of such guide...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-09-01
|
| Series: | BMC Medical Ethics |
| Online Access: | http://www.biomedcentral.com/1472-6939/12/16 |